Argeris N Karabelas - Net Worth and Insider Trading
Argeris N Karabelas Net Worth
The estimated net worth of Argeris N Karabelas is at least $290,788 dollars as of 2024-11-05. Argeris N Karabelas is the Director of Bausch Health Companies Inc and owns about 20,726 shares of Bausch Health Companies Inc (BHC) stock worth over $191,923. Argeris N Karabelas is the Director of Regenxbio Inc and owns about 11,286 shares of Regenxbio Inc (RGNX) stock worth over $98,865. Argeris N Karabelas is also the Director of Vanda Pharmaceuticals Inc and owns about 0 shares of Vanda Pharmaceuticals Inc (VNDA) stock worth over $0. Details can be seen in Argeris N Karabelas's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Argeris N Karabelas has not made any transactions after 2024-10-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Argeris N Karabelas
Argeris N Karabelas Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Argeris N Karabelas owns 5 companies in total, including Regenxbio Inc (RGNX) , Bausch Health Companies Inc (BHC) , and Rocket Pharmaceuticals Inc (RCKT) among others .
Click here to see the complete history of Argeris N Karabelas’s form 4 insider trades.
Insider Ownership Summary of Argeris N Karabelas
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RGNX | Regenxbio Inc | 2024-10-01 | director |
| BHC | Bausch Health Companies Inc | 2017-05-05 | director |
| RCKT | Rocket Pharmaceuticals Inc | 2015-02-17 | director & 10 percent owner |
 | | 2010-03-12 | director & Chairman of the Board |
| | 2009-07-23 | other: See remarks below. |
Argeris N Karabelas Latest Holdings Summary
Argeris N Karabelas currently owns a total of 3 stocks. Among these stocks, Argeris N Karabelas owns 20,726 shares of Bausch Health Companies Inc (BHC) as of August 11, 2016, with a value of $191,923 and a weighting of 66%. Argeris N Karabelas owns 11,286 shares of Regenxbio Inc (RGNX) as of October 1, 2024, with a value of $98,865 and a weighting of 34%. Argeris N Karabelas also owns 0 shares of Vanda Pharmaceuticals Inc (VNDA) as of March 12, 2010, with a value of $0 and a weighting of 0%.
Latest Holdings of Argeris N Karabelas
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BHC | Bausch Health Companies Inc | 2016-08-11 | 20,726 | 9.26 | 191,923 |
| RGNX | Regenxbio Inc | 2024-10-01 | 11,286 | 8.76 | 98,865 |
| VNDA | Vanda Pharmaceuticals Inc | 2010-03-12 | 0 | 4.85 | 0 |
Holding Weightings of Argeris N Karabelas
Argeris N Karabelas Form 4 Trading Tracker
According to the SEC Form 4 filings, Argeris N Karabelas has made a total of 0 transactions in Bausch Health Companies Inc (BHC) over the past 5 years. The most-recent trade in Bausch Health Companies Inc is the acquisition of 4,000 shares on August 11, 2016, which cost Argeris N Karabelas around $98,600.
According to the SEC Form 4 filings, Argeris N Karabelas has made a total of 5 transactions in Regenxbio Inc (RGNX) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Regenxbio Inc is the sale of 10,000 shares on October 1, 2024, which brought Argeris N Karabelas around $101,100.
According to the SEC Form 4 filings, Argeris N Karabelas has made a total of 0 transactions in Vanda Pharmaceuticals Inc (VNDA) over the past 5 years. The most-recent trade in Vanda Pharmaceuticals Inc is the sale of 200,000 shares on March 12, 2010, which brought Argeris N Karabelas around $2 Million.
Insider Trading History of Argeris N Karabelas
- 1
Argeris N Karabelas Trading Performance
GuruFocus tracks the stock performance after each of Argeris N Karabelas's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Argeris N Karabelas is -26.5%. GuruFocus also compares Argeris N Karabelas's trading performance to market benchmark return within the same time period. The performance of stocks bought by Argeris N Karabelas within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Argeris N Karabelas's insider trading performs compared to the benchmark.
Performance of Argeris N Karabelas
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 14.58 | | | | | |
| Relative Return to S&P 500(%) | 17.23 | | | | | |
Argeris N Karabelas Ownership Network
Ownership Network List of Argeris N Karabelas
Ownership Network Relation of Argeris N Karabelas
Argeris N Karabelas Owned Company Details
What does Regenxbio Inc do?
Who are the key executives at Regenxbio Inc?
Argeris N Karabelas is the director of Regenxbio Inc. Other key executives at Regenxbio Inc include SVP of Technical Operations Curran Simpson , director & See Remarks Kenneth T. Mills , and Chief Medical Officer Steve Pakola .
Regenxbio Inc (RGNX) Insider Trades Summary
Over the past 18 months, Argeris N Karabelas made 5 insider transaction in Regenxbio Inc (RGNX) with a net sale of 51,100. Other recent insider transactions involving Regenxbio Inc (RGNX) include a net sale of 180,000 shares made by Kenneth T. Mills , a net sale of 9,748 shares made by Curran Simpson , and a net sale of 12,878 shares made by Steve Pakola .
In summary, during the past 3 months, insiders sold 20,000 shares of Regenxbio Inc (RGNX) in total and bought 0 shares, with a net sale of 20,000 shares. During the past 18 months, 253,726 shares of Regenxbio Inc (RGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 253,726 shares.
Regenxbio Inc (RGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regenxbio Inc Insider Transactions
Argeris N Karabelas Mailing Address
Above is the net worth, insider trading, and ownership report for Argeris N Karabelas. Currently GuruFocus does not have mailing address information for Argeris N Karabelas.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
